Trial Profile
A Randomized Double-Blind, Placebo-Controlled, Multicenter Study of CI-994 Capsules Plus Gemcitabine Infusion Versus Placebo Capsules Plus Gemcitabine Infusion as Second-Line Treatment of Patients With Advanced Nonsmall Cell Lung Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 25 May 2009
Price :
$35
*
At a glance
- Drugs Tacedinaline (Primary) ; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- 04 Sep 2005 New trial record.